MA

Muhammad Altaf Hussain

Active Director Director DIN 09814986
DIN 09814986 First appointment Dec 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Muhammad Altaf Hussain

Data last updated:

Muhammad Altaf Hussain is a Director at Lii Biotech Private Limited (since 2022). The company operates in Chemicals.

DIN 09814986
Primary Designation Director
Industry Chemicals
First Appointment 07 Dec 2022
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lii Biotech Private Limited U24290MH2022PTC394730
Director07 Dec 20222022Active

Board colleagues of Muhammad Altaf Hussain

NameDINCompanyDesignation
Atiqur Rahman09814985Lii Biotech Private LimitedDirector
Manirul Islam08777057Lii Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Lii Biotech Private Limited
Premium access

Shareholding and investment profile for Muhammad Altaf Hussain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Muhammad Altaf Hussain

Muhammad Altaf Hussain currently holds 1 directorship: Lii Biotech Private Limited (Director, since 07 Dec 2022).

Muhammad Altaf Hussain was first appointed on 07 Dec 2022 as Director at Lii Biotech Private Limited.

The current boards of Muhammad Altaf Hussain's companies include Atiqur Rahman (Lii Biotech Private Limited), Manirul Islam (Lii Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available